The treatment landscape of hemophilia A care continues to rapidly evolve. This webinar will explore Genentech's latest research and share updates on investigational treatments currently in development, including a FVIII mimetic and a gene therapy. You will learn about the science behind how these potential treatments work, the latest clinical study results, and information on ongoing and enrolling trials. Sponsored by Genentech.

Speakers: 

Chris Guelcher, Hemostasis RN-BC, MS, PPCNP-BC, Senior MSL, Rare Blood Disorders. Genentech, a Member of the Roche Group

Dakota J. Rosenfelt, PharmD, RPh, MBA, Senior MSL, Rare Blood Disorders, Genentech, a Member of the Roche Group